LYPD1 polyclonal antibody
Product Specifications
Background
Believed to act as a modulator of nicotinic acetylcholine receptors (nAChRs activity. In vitro increases receptor desensitization and decreases affinity for ACh of alpha-4:beta-2-containing nAChRs. May play a role in the intracellular trafficking of alpha-4:beta-2 and alpha-7-containing nAChRs and may inhibit their expression at the cell surface. May be involved in the control of anxiety.
CAS Number
9007-83-4
Structure Composition
1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2
Product Name Alternative
LYPD1; LYPDC1; PHTS
Swiss Prot
Q8N2G4
Reactivity
Mouse
Immunogen
Recombinant fusion protein of human LYPD1 (NP_653187.3) .
Conjugation
Unconjugated
Applications
WB
Dilution
WB,1:1000 - 1:2000
Purity
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE) .
Modification
Unmodification
Molecular Weight
Refer to Figures
Storage Conditions
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Notes
For research use only, not for use in diagnostic procedure.
Specificity
Unmodification
Host or Source
Rabbit
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2925569-01 20 µg
Recombinant Human E3 ubiquitin-protein ligase RNF133 (RNF133)
Sign In for Pricing
View Details orb2925569-02 100 µg
Recombinant Human E3 ubiquitin-protein ligase RNF133 (RNF133)
Sign In for Pricing
View Details 
MRGPRB8-5676M 50 µg
Recombinant Mouse MRGPRB8 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details